Status:

COMPLETED

Perineural Dexamethasone in the Adductor Canal Block

Lead Sponsor:

Olfa kaabachi, MD

Conditions:

Post Operative Pain

Eligibility:

All Genders

Phase:

NA

Brief Summary

Postoperative pain management in total knee arthroplasty (TKA) surgery is a real challenge for the anesthesiologist. Effective pain control must be provided while preserving the mobility to ensure ear...

Detailed Description

Using a computer-generated sequence of random numbers, the patients included will be randomly allocated to get an adductor canal block using : Group D: 10 ml of 0.5% bupivacaine + 10 ml of 0.9% norma...

Eligibility Criteria

Inclusion

  • Patients scheduled for unilateral TKA
  • Surgery under spinal anesthesia
  • ASA class I, II, and III patients

Exclusion

  • Patient refusal to participate in the study
  • Contraindication to regional anesthesia
  • Allergies to the products used
  • Bilateral TKA
  • Revision TKA
  • TKA in the context of inflammatory or post-traumatic disease
  • BMI \> 45
  • Poorly controlled diabetic patients with HbA1c \> 8%
  • Patients on corticosteroid therapy or who have received an intra-articular injection of corticosteroids

Key Trial Info

Start Date :

December 15 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2025

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT06079047

Start Date

December 15 2023

End Date

October 31 2025

Last Update

November 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

KAABACHI

Tunis, La Mannouba, Tunisia, 2010

Perineural Dexamethasone in the Adductor Canal Block | DecenTrialz